May 1, 2024
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a global multi-brand beauty and wellness platform, today announced its participation in the CreatorIQ Connect Europe conference, which will be held in London on Thursday, May 2, 2024.
April 30, 2024
2023 Net Revenue of $218.1 million Group Combined Comparable Revenue of $212.5 million, a 15.3% increase vs 2022 Group Combined Adjusted EBITDA of $24.4 million, up from ($8.8) million in 2022 WHITE PLAINS, N.Y., April 30, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the
March 25, 2024
WHITE PLAINS, N.Y., March 25, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that on March 21, 2024 the Company received formal notice from the Nasdaq Hearings Panel (the “Panel”) confirming that it has regained
March 20, 2024
—  H1’23 Total Net Revenue of $109.3 million —  H1’23 Combined Adjusted EBITDA of $13.9 million up from $7.6 million in H1’22 —  Introduces guidance WHITE PLAINS, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and
February 26, 2024
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced that by decision dated February 22, 2024, a Nasdaq Hearings Panel (the “Panel”) granted Waldencast’s request for continued listing on The
January 31, 2024
NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a global multi-brand beauty and wellness platform, announced today that Manuel Manfredi will join the Company as Chief Financial Officer on April 1, 2024.
January 16, 2024
NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced that it filed its annual report for the fiscal year ended December 31, 2022 on Form 20-F (“2022 20-F”) including restated financials for
Displaying 1 - 10 of 11
Print Page
Investor FAQs
RSS Feeds
Email Alerts
Contact IR